280 related articles for article (PubMed ID: 17635000)
1. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.
Kim SY; Dabb AA; Glenn DJ; Snyder KM; Chuk MK; Loeb DM
Pediatr Blood Cancer; 2008 Apr; 50(4):779-83. PubMed ID: 17635000
[TBL] [Abstract][Full Text] [Related]
2. Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients.
Clark A; Hemmelgarn T; Danziger-Isakov L; Teusink A
Pediatr Transplant; 2015 May; 19(3):326-31. PubMed ID: 25712369
[TBL] [Abstract][Full Text] [Related]
3. Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.
Quinn M; Fannin JT; Sciasci J; Bragg A; Campbell PK; Carias D; Crews KR; Gregornik D; Jeha S; Maron G; Pauley JL; Swanson HD; Wolf J; Greene W
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866879
[No Abstract] [Full Text] [Related]
4. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
[TBL] [Abstract][Full Text] [Related]
5. Safety and Effectiveness of Intravenous Pentamidine for Prophylaxis of Pneumocystis jirovecii Pneumonia in Pediatric Hematology/Oncology Patients.
Solodokin LJ; Klejmont LM; Scipione MR; Dubrovskaya Y; Lighter-Fisher J; Papadopoulos J
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e180-5. PubMed ID: 27164533
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis pneumonia in children receiving chemotherapy.
Prasad P; Nania JJ; Shankar SM
Pediatr Blood Cancer; 2008 Apr; 50(4):896-8. PubMed ID: 17458875
[TBL] [Abstract][Full Text] [Related]
7. Aerosolized pentamidine prophylaxis for Pneumocystis carinii pneumonia after allogeneic marrow transplantation.
Marras TK; Sanders K; Lipton JH; Messner HA; Conly J; Chan CK
Transpl Infect Dis; 2002 Jun; 4(2):66-74. PubMed ID: 12220242
[TBL] [Abstract][Full Text] [Related]
8. Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation.
DeMasi JM; Cox JA; Leonard D; Koh AY; Aquino VM
Pediatr Infect Dis J; 2013 Sep; 32(9):933-6. PubMed ID: 23538522
[TBL] [Abstract][Full Text] [Related]
9. Safe and Effective Prophylaxis with Bimonthly Intravenous Pentamidine in the Pediatric Hematopoietic Stem Cell Transplant Population.
Levy ER; Musick L; Zinter MS; Lang T; Cowan MJ; Weintrub PS; Dvorak CC
Pediatr Infect Dis J; 2016 Feb; 35(2):135-41. PubMed ID: 26418240
[TBL] [Abstract][Full Text] [Related]
10. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia.
Weinthal J; Frost JD; Briones G; Cairo MS
J Clin Oncol; 1994 Jan; 12(1):136-40. PubMed ID: 8270969
[TBL] [Abstract][Full Text] [Related]
11. No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kato S; Kasahara S; Iseki T; Tojo A; Asano S
Transpl Infect Dis; 2008 Oct; 10(5):303-7. PubMed ID: 18564982
[TBL] [Abstract][Full Text] [Related]
12. Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Vasconcelles MJ; Bernardo MV; King C; Weller EA; Antin JH
Biol Blood Marrow Transplant; 2000; 6(1):35-43. PubMed ID: 10707997
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of intravenous pentamidine for Pneumocystis jirovecii pneumonia prophylaxis in adult patients with hematologic malignancies-its utility during respiratory virus pandemics.
Liew YX; Ho AYL; Wong GC; Chung SJ; Tan TT; Tan BH
Int J Infect Dis; 2024 Jun; 143():107059. PubMed ID: 38615824
[TBL] [Abstract][Full Text] [Related]
14. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
17. Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease.
Kimura M; Tanaka S; Ishikawa A; Endo H; Hirohata S; Kondo H
Rheumatol Int; 2008 May; 28(7):673-6. PubMed ID: 18080124
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
Evans RA; Clifford TM; Tang S; Au T; Fugit AM
Transpl Infect Dis; 2015 Dec; 17(6):816-21. PubMed ID: 26369753
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of intravenous pentamidine isethionate for Pneumocystis jiroveci prophylaxis in a pediatric oncology population.
Orgel E; Rushing T
Pediatr Infect Dis J; 2014 Mar; 33(3):319-21. PubMed ID: 24030353
[TBL] [Abstract][Full Text] [Related]
20. Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy.
Shankar SM; Nania JJ
Paediatr Drugs; 2007; 9(5):301-9. PubMed ID: 17927302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
